Skip to main content
Top
Published in: International Journal of Clinical Pharmacy 4/2012

01-08-2012 | Short Research Report

The evaluation of a novel model of providing ward pharmacy services

Authors: Bryony Dean Franklin, Mario Borges Rosa, Gavin Miller, Ann Jacklin

Published in: International Journal of Clinical Pharmacy | Issue 4/2012

Login to get access

Abstract

Background In UK hospitals, traditional ward pharmacy services involve pharmacists visiting their wards once or twice a day each weekday. However, to provide a more patient orientated ward pharmacy service, we developed the Imperial Model of Ward Pharmacy. This is based on pharmacists seeing every drug chart every other day, allowing increased focus towards patients’ needs on other days. Objective To assess the impact of the Imperial Model of Ward Pharmacy on the prevalence of new medication orders that have not been screened by pharmacists, and doses omitted due to medication being unavailable. Method We conducted an uncontrolled before-and-after study on eight medical wards. In each phase, we collected data on the number and prevalence of active medication orders that had not been screened by a pharmacist at the point of data collection, and the number and prevalence of regular doses documented as being omitted due to drug unavailability, or for which the administration record was left blank. Results The prevalence of unscreened medication orders reduced from 7.6 % of 1,433 orders to 4.1 % of 1,495 orders (p = 0.0002; Chi square test). There was no change in the prevalence of dose omissions (1.4 % in each phase of the study). Conclusion This is a practical way to move to a more patient-focused service without affecting the safety of the service provided.
Appendix
Available only for authorised users
Literature
1.
go back to reference Gillespie U, Alassaad A, Henrohn D, Garmo H, Hammarlund-Udenaes M, Toss H, Kettis-Lindblad A, Melhus H, Morlin C. A comprehensive pharmacist intervention to reduce morbidity in patients 80 years or older: a randomized controlled trial. Arch Intern Med. 2009;169:894–900.PubMedCrossRef Gillespie U, Alassaad A, Henrohn D, Garmo H, Hammarlund-Udenaes M, Toss H, Kettis-Lindblad A, Melhus H, Morlin C. A comprehensive pharmacist intervention to reduce morbidity in patients 80 years or older: a randomized controlled trial. Arch Intern Med. 2009;169:894–900.PubMedCrossRef
2.
go back to reference Hellstrom LM, Bondesson A, Hoglund P, Midlov P, Holmdahl L, Rickhag E, Eriksson T. Impact of the Lund Integrated Medicines Management (LIMM) model on medication appropriateness and drug-related hospital revisits. Eur J Clin Pharmacol. 2011;67:741–52.PubMedCrossRef Hellstrom LM, Bondesson A, Hoglund P, Midlov P, Holmdahl L, Rickhag E, Eriksson T. Impact of the Lund Integrated Medicines Management (LIMM) model on medication appropriateness and drug-related hospital revisits. Eur J Clin Pharmacol. 2011;67:741–52.PubMedCrossRef
3.
go back to reference Bergkvist A, Midlov P, Hoglund P, Larsson L, Eriksson T. A multi-intervention approach on drug therapy can lead to a more appropriate drug use in the elderly. LIMM-Landskrona Integrated Medicines Management. J Eval Clin Pract. 2009;15:660–7.PubMedCrossRef Bergkvist A, Midlov P, Hoglund P, Larsson L, Eriksson T. A multi-intervention approach on drug therapy can lead to a more appropriate drug use in the elderly. LIMM-Landskrona Integrated Medicines Management. J Eval Clin Pract. 2009;15:660–7.PubMedCrossRef
4.
go back to reference Scullin C, Scott MG, Hogg A, McElnay JC. An innovative approach to integrated medicines management. J Eval Clin Pract. 2007;13:781–8.PubMedCrossRef Scullin C, Scott MG, Hogg A, McElnay JC. An innovative approach to integrated medicines management. J Eval Clin Pract. 2007;13:781–8.PubMedCrossRef
5.
go back to reference Brock TP, Franklin BD. Differences in pharmacy terminology and practice between the United Kingdom and the United States. Am J Health Syst Pharm. 2007;64:1541–6.PubMedCrossRef Brock TP, Franklin BD. Differences in pharmacy terminology and practice between the United Kingdom and the United States. Am J Health Syst Pharm. 2007;64:1541–6.PubMedCrossRef
6.
go back to reference McRobbie D, Bednall R, West R. Re-engineering clinical pharmacy services for general medical wards. Pharma J. 2002;269:69–71. McRobbie D, Bednall R, West R. Re-engineering clinical pharmacy services for general medical wards. Pharma J. 2002;269:69–71.
7.
go back to reference Morris J, Savage A, Armstrong D. Evaluation of a team-based clinical service for surgical inpatients. Clin Pharm. 2009;1:287–8. Morris J, Savage A, Armstrong D. Evaluation of a team-based clinical service for surgical inpatients. Clin Pharm. 2009;1:287–8.
8.
go back to reference NICE/NPSA Technical patient safety solutions for medicines reconciliation on admission of adults to hospital. London: 2007. NICE/NPSA Technical patient safety solutions for medicines reconciliation on admission of adults to hospital. London: 2007.
9.
go back to reference Franklin BD, Reynolds M, Burnett S, Shibl N, Jacklin A. Prescribing errors in hospital inpatients: a three-centre study of their prevalence, types and causes. Postgrad Med J. 2011;87:739–45.PubMedCrossRef Franklin BD, Reynolds M, Burnett S, Shibl N, Jacklin A. Prescribing errors in hospital inpatients: a three-centre study of their prevalence, types and causes. Postgrad Med J. 2011;87:739–45.PubMedCrossRef
Metadata
Title
The evaluation of a novel model of providing ward pharmacy services
Authors
Bryony Dean Franklin
Mario Borges Rosa
Gavin Miller
Ann Jacklin
Publication date
01-08-2012
Publisher
Springer Netherlands
Published in
International Journal of Clinical Pharmacy / Issue 4/2012
Print ISSN: 2210-7703
Electronic ISSN: 2210-7711
DOI
https://doi.org/10.1007/s11096-012-9650-2

Other articles of this Issue 4/2012

International Journal of Clinical Pharmacy 4/2012 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine